Most clients with DSM-5® diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.
This recording will update and increase your knowledge of:
Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this recording is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders.
You will leave this recording with knowledge and confidence regarding effective and safe application of pharmacological drugs.
| Manual – Psychopharmacology for Mental Health Professionals (4.48 MB) | 65 Pages | Available after Purchase |
PSYCHOPHARMACOLOGICAL FOUNDATIONS
Core Pharmacological Principles
Your Role in Combined Psychological & Pharmacological Treatments
DRUGS USED IN THE TREATMENT OF DSM-5® MENTAL DISORDERS
Depressive Disorders
Schizophrenia Spectrum Disorders
Bipolar Disorders
Anxiety, Obsessive-Compulsive & Sleep-Wake Disorders
Attention-Deficit/Hyperactivity Disorder & Neurocognitive Disorders (Dementia)
Prescription Drug Abuse
LIMITATIONS OF RESEARCH AND POTENTIAL RISKS
Alan Bloom, Ph.D., is a professor of pharmacology and toxicology at the Medical College of Wisconsin. He earned a joint Ph.D. in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases. Dr. Bloom has conducted extensive research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA center grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin. He is a strong and experienced presenter providing lively, information-packed seminars.
Speaker Disclosures:
Speaker Disclosures: Speaker Disclosure: Financial: Alan Bloom is a Professor of Pharmacology and Toxicology at the Medical College of Wisconsin. He receives a speaking honorarium from PESI, Inc.
Non-financial: Alan Bloom is the vice-chair for the State of Wisconsin Controlled Substances Board.
Course Requirement: Alan S. Bloom – Psychopharmacology for Mental Health Professionals
Real Value: $219.99
One time cost: USD 59.99
Check more original content of Alan S. Bloom – Psychopharmacology for Mental Health Professionals
Our support staff is the best by far! please do not hesitate to contact us at email: [email protected] and we’ll be happy to help!
You want to get “Alan S. Bloom – Psychopharmacology for Mental Health Professionals” now right?!!!
YES! I’M READY TO ADD TO CART BUTTON ON THIS PAGE NOW !
